T1	PrimaryOutcome 33 48	clinical status
T2	TimeFrame 59 69	at 15 days
R1	MeasuredAt Arg1:T1 Arg2:T2	
T3	OutcomeDefinition 70 476	using a six-level ordinal scale as follows: (1) not admitted to hospital; (2) admitted to hospital and not using supplemental oxygen; (3) admitted to hospital and using supplemental oxygen; (4) admitted to hospital and using non-invasive positive-pressure ventilation or high-flow nasal cannula; (5) admitted to hospital and on mechanical ventilation or extracorporeal membrane oxygen support; or (6) death
R2	DefinedAs Arg1:T1 Arg2:T3	
T4	SecondaryOutcome 508 517	mortality
T5	TimeFrame 518 548	at 29 days after randomisation
R3	MeasuredAt Arg1:T4 Arg2:T5	
T6	SecondaryOutcome 580 595	clinical status
T7	OutcomeDefinition 596 635	assessed by the six-point ordinal scale
R4	DefinedAs Arg1:T6 Arg2:T7	
T8	TimeFrame 636 657	at 7 days and 29 days
R5	MeasuredAt Arg1:T6 Arg2:T8	
T9	SecondaryOutcome 659 698	length of hospital stay among survivors
T10	SecondaryOutcome 700 732	incidence of secondary infection
T11	OutcomeDefinition 738 807	new infections arising after randomisation, whether nosocomial or not
R6	DefinedAs Arg1:T10 Arg2:T11	
T12	SecondaryOutcome 814 844	number of ventilator-free days
T13	TimeFrame 845 855	by day 29.
R7	MeasuredAt Arg1:T12 Arg2:T13	
